Information Journal Paper
APA:
CopyBARTZ SCHMIDT, K.U., & HOLZ, F.G.. (2006). INTRODUCTION TO THE TOPIC: OFF-LABEL USE OF BEVACIZUMAB IN THE TREATMENT OF NEOVASCULAR AGE-RELATED MACULAR DEGENERATION. DER OPHTHALMOLOGE : ZEITSCHRIFT DER DEUTSCHEN OPHTHALMOLOGISCHEN GESELLSCHAFT (OPHTHALMOLOGE), 103(6), 461-462. SID. https://sid.ir/paper/549713/en
Vancouver:
CopyBARTZ SCHMIDT K.U., HOLZ F.G.. INTRODUCTION TO THE TOPIC: OFF-LABEL USE OF BEVACIZUMAB IN THE TREATMENT OF NEOVASCULAR AGE-RELATED MACULAR DEGENERATION. DER OPHTHALMOLOGE : ZEITSCHRIFT DER DEUTSCHEN OPHTHALMOLOGISCHEN GESELLSCHAFT (OPHTHALMOLOGE)[Internet]. 2006;103(6):461-462. Available from: https://sid.ir/paper/549713/en
IEEE:
CopyK.U. BARTZ SCHMIDT, and F.G. HOLZ, “INTRODUCTION TO THE TOPIC: OFF-LABEL USE OF BEVACIZUMAB IN THE TREATMENT OF NEOVASCULAR AGE-RELATED MACULAR DEGENERATION,” DER OPHTHALMOLOGE : ZEITSCHRIFT DER DEUTSCHEN OPHTHALMOLOGISCHEN GESELLSCHAFT (OPHTHALMOLOGE), vol. 103, no. 6, pp. 461–462, 2006, [Online]. Available: https://sid.ir/paper/549713/en